Durable Response to Talimogene Laherparepvec (TVEC) Therapy in Advanced Melanoma

4 Views
Published
General Surgery Resident Dr. Baylee Bakilla presents "Durable Response to Talimogene Laherparepvec (TVEC) Therapy in Advanced Melanoma: Regional Therapy as an Adjunct or Replacement for Surgical Resection?" at Stanford Surgery's annual Holman Day celebration on May 9, 2025.

For more information about Stanford University's Department of Surgery, please visit our website: surgery.stanford.edu
Category
Oncology
Be the first to comment